Results 231 to 240 of about 257,683 (336)
Bezlotoxumab as Treatment for Recurrent/Chronic Clostridioides difficile Infection in Pediatric Stem Cell Transplant Recipients: A Multi‐Institutional Experience
Pediatric Blood &Cancer, EarlyView.ABSTRACT
Clostridioides difficile infection (CDI) represents a significant health risk to pediatric stem cell transplant (SCT) patients. In these patients, recurrent CDI is common, requiring prolonged antibiotic usage and increased hospitalization. Bezlotoxumab, a monoclonal antibody that targets the toxin responsible for CDI, has demonstrated efficacy Aaron E. Fan, Shaikha Alqahtani, Natalie Dailey Garnes, Priti Tewari, Demetrios Petropoulos, Sajad Khazal, Kris Mahadeo, Paige DePriest, Irtiza N. Sheikh +8 morewiley +1 more sourceTandem High‐Dose Chemotherapy and Autologous Stem Cell Transplantation for Osteosarcoma with Initial Pulmonary Metastases
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background
Although the survival rates of patients with localized osteosarcoma have significantly improved, metastatic osteosarcoma still has a poor prognosis. The role of high‐dose chemotherapy and autologous stem cell transplantation (HDC/ASCT) in high‐risk osteosarcoma remains unclear compared to that of conventional chemotherapy, and an ...Hyun Jin Park, Kyung Taek Hong, Jung Yoon Choi, Bo Kyung Kim, Han‐Soo Kim, Samina Park, Sung‐Hye Park, Jung‐Eun Cheon, Hyoung Jin Kang +8 morewiley +1 more sourceEfficacy and safety of tacrolimus versus cyclophosphamide therapy for Henoch-Schönlein purpura nephritis in children: A systematic review. [PDF]
Medicine (Baltimore)Jiang W, Li X, Liu X, Zhang C, Lu G, Yang J, Qiao L, Bai Y, Zhou C, Niu Q, Luo Q, Zhong W, Kong F, Zhou W, Yin C, Tang W, Xu W. +16 moreeuropepmc +1 more sourceHigh Prevalence of Abnormal Baseline Lung Function in Pediatric and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Report from the TRANSPIRE Study
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background
Pulmonary complications are a major cause of morbidity and mortality in pediatric and young adult hematopoietic stem cell transplant (HSCT) recipients. The impact of preexisting lung dysfunction on posttransplant outcomes remains understudied. Methods
In a multi‐institutional prospective cohort of 444 patients (≤24 years) undergoing Jane Koo, Richard Cooper, Stephanie L. Edwards, Adam Lane, Sara Katherine Loveless, Lauren Strecker, Kelly E. Lake, Kasiani C Myers, Christopher Towe, Jessica Patti, Laura L. Walkup, Kathryn A. Wikenheiser‐Brokamp, Margaret L. MacMillan, Philip Lacher, Tamara Griffin, Merve Tekman, Gabriel Salinas Cisneros, Kevin Wu, Matthew S. Zinter, Fernando A. Urrego, K. Scott Baker, Matthew F. Abts, Sheri Ballard, Jason L. Freedman, Alexander Caraballo, Lisa R. Young, Maureen B. Josephson, Julian L. Allen, Devaney M. Camburn, Erin E Doherty, Mashid Sababi Azamian, Martha Arredondo, Manuel Silva‐Carmona, Leslie E. Lehmann, Wai Wong, Jonathan M. Gaffin, William McAlpine, Mona Li, Samuel B. Goldfarb, Jason C. Woods, Stella M. Davies +40 morewiley +1 more sourceMultipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Nature Network Boston, 2012 S. Walter, T. Weinschenk, A. Stenzl, R. Zdrojowy, A. Płużańska, C. Szczylik, M. Staehler, W. Brugger, P. Dietrich, R. Mendrzyk, N. Hilf, O. Schoor, J. Fritsche, A. Mahr, D. Maurer, Verona Vass, C. Trautwein, Peter Lewandrowski, C. Flohr, H. Pohla, J. Stańczak, V. Bronte, S. Mandruzzato, T. Biedermann, G. Pawelec, E. Derhovanessian, H. Yamagishi, T. Miki, F. Hongo, N. Takaha, K. Hirakawa, Hiroaki Tanaka, S. Stevanović, J. Frisch, A. Mayer-Mokler, A. Kirner, H. Rammensee, C. Reinhardt, H. Singh-Jasuja +38 moresemanticscholar +1 more sourceNew Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor Committee
Pediatric Blood &Cancer, EarlyView.ABSTRACT
Outcomes for relapsed Ewing sarcoma remain consistently poor. Continued efforts to consider creative new approaches for the treatment of relapsed Ewing sarcoma are needed. The Children's Oncology Group Bone Tumor Committee convened a New Strategies for Ewing Sarcoma Task Force to systematically evaluate agents for inclusion in future Phase II ...Jessica D. Daley, Susan L. Whiteway, Christine M. Heske, Filemon S. Dela Cruz, Sarah B. Whittle, Sarah Cohen‐Gogo, Anderson B. Collier, Ajay Gupta, Joyce Ohm, Andrew Clark, Alice Soragni, Elizabeth Lawlor, Bhuvana Setty, Patrick J. Grohar, Katie Janeway, Damon R. Reed, Emily K. Slotkin, Kelly M. Bailey +17 morewiley +1 more source